Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics

Journal of Pharmaceutical Sciences

Volumn 87, Issue 6, 1998, Pages 732-737

  Sun, Yu Nien ^a   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARTMENT MODEL; PHARMACOKINETICS; PROBABILITY; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION; STOCHASTIC MODEL;

EID: 0031835741     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970414z     Document Type: Article

References (29)

1. Lauggengurger, D. A.; Linderman, J. J. Signal transduction. Receptors, Modeling for Binding, Trafficking, and Signaling; Oxford University Press: New York, 1993; Chapt. 5, pp 181-235.
2. Lodish, H.; Baltimore, D.; Berk, A.; Zipursky, S. L.; Matsudaira, P.; Darnell, J. Cell-to-cell signaling: Hormones and receptors. Molecular Cell Biology, 3th ed.; Scientific American Books, Inc.: New York, 1995; Chapter 20, pp 853-924.
3. Cooney, A. J.; Tsai, S. Y. Nuclear receptor-DNA interactions. In Mechanism of Steroid Hormone Regulation of Gene Transcription; Tsai, M-J., O'Malley, B. W., Eds.; R. G. Landes Company: Austin, TX, 1994; pp 25-59.
4. Elsas, L. J., II; Longo, N.; Langley, S.; Griffin, L. D.; Shuster, R. C. Molecular genetics of severe insulin resistance. Yale J. Biol. Med. 1989, 62, 533-547.
5. Ross, E. M.; Gilman, A. G. Resolution of some components of adenylate cyclase necessary for catalytic activity. J. Biol. Chem. 1977, 252, 6966-6969.
6. Tingley, D. W. Evolutions: steroid-hormone receptor signaling. J. NIH Res. 1996, 8, 81-88.
7. Pettit, E. J.; Hallett, M. B. Early signaling events in neutrophils detected by rapid confocal laser scanning. Biochem. J. 1995, 310, 445-448.
8. Xu, Z.-X.; Sun, Y.-N.; DuBois, D. C.; Almon, R. R.; Jusko, W. J. Third-generation model for corticosteroid pharmacodynamics: Roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver. J. Pharmacokinet. Biopharm. 1995, 23, 163-181.
9. Alfieri-Rolla, G.; Segre, G. The effect of carbon tetrachloride on the kinetics of bromsulphalein clearance in the rabbit. Eur. J. Pharmacol. 1968, 3, 330-336.
10. Berman, M.; Hoff, E.; Barandes, M.; Becker, D. V.; Sonenberg, M.; Benua, R.; Koutras, D. A. Iodine kinetics in man -a model. J. Clin. Endocrinol. Metab. 1968, 28, 1-14.
11. Krejcie, T. C.; Jacquez, J. A.; Avram, M. J.; Niemann, C. U.; Shanks, C. A.; Henthorn, T. K. Use of parallel Erlang density functions to analyze first-pass pulmonary uptake of multiple indicators in dogs. J. Pharmacokinet. Biopharm. 1996, 24, 569-588.
12. 2+ signaling in neutrophils. J. Theoret. Biol. 1997, 186, 1-6.
13. Bischoff, K. B.; Dedrick, R. L.; Zaharko, D. S.; Longstreth, J. A. Methotrexate pharmacokinetics. J. Pharm. Sci. 1971, 60, 1128-1133.
14. Branehög, I. Platelet kinetics in idiopathic thrombocytopenic purpura (ITP) before and at different times after splenectomy. Br. J. Haematol. 1975, 29, 413-426.
15. Scheffel, U.; Tsan, M.-F.; Mitchell, T. G.; Camargo, E. E.; Braine, H.; Ezekowitz, M. D.; Nickoloff, L.; Hill-Zobel, R.; Murphy, E.; McIntyre, P. A. Human platelets labeled with In-111 8-hydroxyquinoline: Kinetics, distribution, and estimates of radiation dose. J. Nucl. Med. 1982, 23, 149-156.
16. Kalbfleisch, J. G. Probability. Probability and Statistical Inference, 2nd ed.; Springer-Verlag Inc.: New York; Volume 1, 1985.
17. Ariëns, E. J. Affinity and intrinsic activity m the theory of competitive inhibition. Arch. Int. Pharmacodyn. Ther. 1954, 99, 32-49.
18. D'Argenio, D. Z.; Schumitzky, A. ADAPT II User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software. Biomedical Simulation Resource, Los Angeles, 1997.
19. Sheiner, L. B.; Stanski, D. R.; Vozeh, S.; Miller, R. D.; Ham, J. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin. Pharmacol. Ther. 1979, 25, 358-371.
20. Dayneka, N. L.; Garg, V.; Jusko, W. J. Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokinet. Biopharm. 1993, 21, 457-478.
21. Jusko, W. J.; Ko, H. C.; Ebling, W. F. Convergence of direct and indirect pharmacodynamic response models. J. Pharmacokinet. Biopharm. 1995, 23, 5-8.
22. Nichols, A. I.; Boudinot, F. D.; Jusko, W. J. Second generation model for prednisolone pharmacodynamics in the rat. J. Pharmacokinet. Biopharm. 1989, 17, 209-227.
23. DuBois, D. C.; Almon, R. R.; Jusko, W. J. Molar quantification of specific messenger ribonucleic acid expression in Northern hybridization using cRNA standards. Anal. Biochem. 1993, 210, 140-144.
24. Sun, Y.-N.; DuBois, D. C.; Almon, R. R.; Jusko, W. J. Unpublished results. Fourth-generation model for corticosteroid pharmacodynamics: A model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction m rat liver J. Pharmacokin. Biopharm., submitted.
25. Okabayashi, Y.; Maddux, B. A.; McDonald, A. R.; Logsdon, C. D.; Williams, J. A.; Goldfine, I. D. Mechanism of insulin-induced insulin-receptor down-regulation: Decrease of receptor biosynthesis and mRNA levels. Diabetes 1989, 38, 182-187.
26. Hauguel-de-Mouzon, A.; Mrejen, C.; Alengrin, F.; Obberghen, E. V. Glucose-induced stimulation of human insulin-receptor mRNA and tyrosine kinase activity in cultured cells. Biochem. J. 1995, 305, 119-124.
27. Hadcock, J. R.; Malbon, C. C. Down-regulation of β-adrenergic receptors: Agonist-induced reduction in receptor mRNA levels Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 5021-5025.
28. Aarons, R. D.; Nies, A. S.; Gal, J.; Hegstrand, L. R.; Molinoff, P. B. Elevation of β-adrenergic receptor density in human lymphocytes after propranolol administration. J. Clin. Invest. 1980, 65, 949-957.
29. Lima, J. J.; Krukemyer, J. J.; Boudoulas, H. Drug-or hormone-induced adaptation: Model of adrenergic hypersensitivity. J. Pharmacokinet. Biopharm. 1989, 17, 347-364.